antibody

  1. John Mac

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1607353/abstract Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) entails low quality of life for patients and massive societal costs. There is an urgent need for elucidation of disease mechanisms...
  2. SNT Gatchaman

    The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms, 2023, Buck et al.

    The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms Amanda M. Buck; Amelia N. Deitchman; Saki Takahashi; Scott Lu; Sarah A. Goldberg; Aaron Bodansky; Andrew Kung; Rebecca Hoh; Meghann C. Williams; Marian Kerbleski...
  3. John Mac

    Investigating antibody reactivity to the intestinal microbiome in severe myalgic encephalomyelitis/chronic fatigue syndrome 2023 Carding et al

    Full title: Investigating antibody reactivity to the intestinal microbiome in severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Preprint Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystemic disease of unknown aetiology that is characterised...
    • John Mac
    • Thread
    • antibody carding igg immune dysfunction intestinal microbiome microbiome severe me
    • Replies: 3
    • Forum: ME/CFS research
  4. ME/CFS Skeptic

    Preprint: Mental health of Adolescents in the Pandemic: Long-COVID19 or Long-Pandemic Syndrome?, 2021, Blankenburg et al.

    Abstract Background Post-COVID19 complications such as pediatric inflammatory multisystem syndrome (PIMS) and Long-COVID19 move increasingly into focus, potentially causing more harm in this age group than the acute infection. To better understand the symptoms of long-COVID19 in adolescents and...
  5. D

    First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People

    First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People, 2021, MassBiologics, Phase I Study Type : Interventional (Clinical Trial) Estimated Enrollment : 48 participants Allocation: Randomized Intervention...
  6. L

    Antibody for SARS -CoV- 2

    Antibody for SARS -CoV- 2 https://www.biorxiv.org/content/10.1101/2020.03.11.987958v1.full.pdf+html As I remember it an antibody can be used for passive immunisation to reduce deaths in infected individuals. @Jonathan Edwards
  7. Andy

    A Functional Cell-Based Bioassay for Assessing Adrenergic Autoantibody Activity in Postural Tachycardia Syndrome, 2019, Raj et al

    Open access at www.sciencedirect.com/science/article/pii/S2589909019300061
Back
Top Bottom